Heim » Alle » Aktienprognose » Uro Gen Pharma Ltd. Ordinary Shares Vorhersage

Uro Gen Pharma Ltd. Ordinary Shares Vorhersage: Morgen, Woche, Monat, 5 Jahre

Aktualisiert: April 22 · 2026 at 07:03 UTC
▲ +0.44%Market Cap $1.22B · Technical analysis Bullish · Focus area Price + volatility

Prognosezusammenfassung

ZeitrahmenVoraussichtlicher PreisVergangenheitHistorischEinblick
Morgen$24.85 -0.71%Gestern$25.10 +0.30%Tomorrow's UroGen Pharma Ltd. Ordinary Shares (URGN) setup is anchored to $25.03 and targets $24.85 (-0.71%). The near-term read is downside; watch $25.78 / $24.28 because daily realized volatility is about 3.65%.
Tomorrow's UroGen Pharma Ltd. Ordinary Shares (URGN) setup is anchored to $25.03 and targets $24.85 (-0.71%). The near-term read is downside; watch $25.78 / $24.28 because daily realized volatility is about 3.65%.
Woche$24.48 -2.20%Letzte Woche$25.26 +0.92%The 7-day UroGen Pharma Ltd. Ordinary Shares model moves from $25.26 to $24.48 (-2.20%). It gives downside momentum context for this stock, so breaks around $25.78 / $24.28 matter more than a single tick.
The 7-day UroGen Pharma Ltd. Ordinary Shares model moves from $25.26 to $24.48 (-2.20%). It gives downside momentum context for this stock, so breaks around $25.78 / $24.28 matter more than a single tick.
Monat$23.86 -4.69%Letzten Monat$25.52 +1.97%The 1-month UroGen Pharma Ltd. Ordinary Shares target is $23.86 (-4.69%), compared with the live reference near $25.03. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month UroGen Pharma Ltd. Ordinary Shares target is $23.86 (-4.69%), compared with the live reference near $25.03. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Jahr$22.92 -8.41%Letztes Jahr$25.91 +3.53%The 1-year UroGen Pharma Ltd. Ordinary Shares scenario points to $22.92 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year UroGen Pharma Ltd. Ordinary Shares scenario points to $22.92 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Jahre$20.74 -17.14%Vor 5 Jahren$26.83 +7.20%The 5-year UroGen Pharma Ltd. Ordinary Shares view is $20.74 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year UroGen Pharma Ltd. Ordinary Shares view is $20.74 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Morgen$24.85 -0.71%
Gestern$25.10 +0.30%
Tomorrow's UroGen Pharma Ltd. Ordinary Shares (URGN) setup is anchored to $25.03 and targets $24.85 (-0.71%). The near-term read is downside; watch $25.78 / $24.28 because daily realized volatility is about 3.65%.
Woche$24.48 -2.20%
Letzte Woche$25.26 +0.92%
The 7-day UroGen Pharma Ltd. Ordinary Shares model moves from $25.26 to $24.48 (-2.20%). It gives downside momentum context for this stock, so breaks around $25.78 / $24.28 matter more than a single tick.
Monat$23.86 -4.69%
Letzten Monat$25.52 +1.97%
The 1-month UroGen Pharma Ltd. Ordinary Shares target is $23.86 (-4.69%), compared with the live reference near $25.03. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Jahr$22.92 -8.41%
Letztes Jahr$25.91 +3.53%
The 1-year UroGen Pharma Ltd. Ordinary Shares scenario points to $22.92 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Jahre$20.74 -17.14%
Vor 5 Jahren$26.83 +7.20%
The 5-year UroGen Pharma Ltd. Ordinary Shares view is $20.74 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Preisdiagramm

HistorischVorhersageBullischBärisch
$25.60$25.20$24.79$24.39$23.991W AgoNow7D F

Technische Analyse

VerkaufenNeutralKaufen
Neutral
1
Bullisch
3
Neutral
1
Bärisch

Schlüsselindikatoren

IndikatorWertSignal
Price$25.03 Mid
Daily Change+0.44% Above
Volatility Cap20.0% Mid
Confidence58% Below
Data Sourcenasdaq-screener Mid

Historische Daten

Current$25.03
Daily Change+0.44%
Market Cap$1.22B
Sourcenasdaq-screener
Current$25.03Daily Change+0.44%
Market Cap$1.22BSourcenasdaq-screener

Unterstützungs- und Widerstandsniveaus

$24.28Support 1
$25.03Aktuell
$25.78Resistance 1
shield
Support and resistance are estimated from the trusted current price until deeper historical data is available.

Preismeilensteine

Schlüsselebenen und historischer Kontext
Current$25.03Live reference price
Used as the anchor for generated forecast calculations.
Next Month$23.86Model projection-4.69%
Directional scenario based on capped drift.

Prognosegenauigkeit

Wie unser Modell funktioniert hat
58%
Richtungsweisend
Generated market-data forecast
This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.
📊
Unser Algorithmus wird wöchentlich unter Verwendung der neuesten Preisbewegungen, Volatilitätsregime und Indikatorsignale neu kalibriert. Die Genauigkeit variiert je nach Zeitrahmen – kurzfristige Impulse sind zuverlässiger als langfristige Prognosen.
Short term
58%
Direction confidence
Long term
Lower
Forecast uncertainty rises with horizon

Investitionsszenarien

Wenn Sie heute $1,000 in URGN investieren
Bullish Scenario
$26.28
+5.00% from current
Zielpreis$26.28
SzenarioUpside momentum
Wahrscheinlichkeit50%
Base Scenario
$23.86
-4.69%
Zielpreis$23.86
SzenarioCapped drift
Wahrscheinlichkeit58%
Bearish Scenario
$23.78
-5.00% from current
Zielpreis$23.78
SzenarioVolatility drawdown
Wahrscheinlichkeit42%
Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Prognosefaktoren

Market Structure
Price structure reflects the latest momentum regime and support/resistance interaction.
Momentum Bearish · 40/100
24H drift-0.71%
7D drift-2.20%
30D drift-4.69%
Technical Signals
Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.
Mixed — Watching · 50/100
RSIn/a
MACDn/a
MA stackn/a
Macro Context
Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.
Risk-Off Caution · 35/100
1M outlook-4.69%
1Y outlook-8.41%
5Y outlook-17.14%

Häufig gestellte Fragen

Q What is the UroGen Pharma Ltd. Ordinary Shares (URGN) forecast for tomorrow?
Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), UroGen Pharma Ltd. Ordinary Shares is projected near $24.85 versus the current reference around $25.03. That implies a modeled move of -0.71% over the next day, with realized prices still sensitive to intraday volatility.
Q What does the 7-day stock outlook suggest for URGN?
The weekly UroGen Pharma Ltd. Ordinary Shares model points to $24.48, which maps to an expected drift of -2.20% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.
Q How should I read the UroGen Pharma Ltd. Ordinary Shares 1-month and 1-year targets?
The UroGen Pharma Ltd. Ordinary Shares 1-month target is $23.86 (-4.69%), while the 1-year target is $22.92 (-8.41%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.
Q Why does the UroGen Pharma Ltd. Ordinary Shares 5-year scenario differ from short-term rows?
The UroGen Pharma Ltd. Ordinary Shares long-horizon scenario sits near $20.74 with a modeled change of -17.14%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.
Q Where are URGN support and resistance zones right now?
For UroGen Pharma Ltd. Ordinary Shares, nearest resistance is around $24.28, while nearest support is around $25.78. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.
Q How fresh is the UroGen Pharma Ltd. Ordinary Shares market snapshot?
The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.